Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
Dextroamphetamine adipate
(S)-amphetamine
(S)-(+)-β-phenylisopropylamine
Desamfetamina
Dextroamphetamine sulfate
(+)-α-methylphenylethylamine
(+)-(S)-amphetamine
Dextroamphetamine saccharate
(αS)-α-methylbenzeneethanamine
(S)-(+)-amphetamine
Dexamphetamine
(+)-α-methylphenethylamine
(+)-amphetamine
Dexanfetamina
Dexamfetamina
d-amphetamine
(S)-α-methylbenzeneethanamine
(S)-1-phenyl-2-aminopropane
Dexamfetamine
Dextroamphetamine
Dexamfetaminum
(S)-1-phenyl-2-propylamine
Brand Names
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682